Mitoxantrone Completed Phase 2 Trials for Mesothelioma

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT02467426Isolated Thoracic Perfusion (ITP-F) for MPM